Priority Date: 15.04.10 (US 20100324678P)

OXAZOLE AND THIAZOLE COMPOUNDS AS KSP INHIBITORS

  • Application ID: EP11714061
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.04.2010 - Priority Date (US 20100324678P)
  • 20.10.2011 - Publication A2 (WO2011128388)
  • 20.02.2013 - Publication A2 (EP2558452)